theratechnologies
appoints
two
new
board
members
montreal
globe
newswire
theratechnologies
theratechnologies
tsx
th
nasdaq
thtx
biopharmaceutical
company
focused
development
commercialization
innovative
therapies
today
announced
appointment
andrew
molson
alain
trudeau
new
independent
members
board
directors
andrew
alain
bring
tremendous
value
board
respected
peers
business
community
knowledge
expertise
vision
said
ms
dawn
svoronos
chair
board
theratechnologies
behalf
board
directors
theratechnologies
pleasure
welcome
look
forward
important
contribution
andrew
alain
make
theratechnologies
enters
new
chapter
history
theratechnologies
recently
announced
intent
develop
tesamorelin
treatment
nonalcoholic
steatohepatitis
nash
general
population
continues
advance
technologytm
platform
oncology
programs
along
commercialization
egrifta
position
theratechnologies
become
much
larger
player
pharmaceutical
industry
added
svoronos
andrew
molson
andrew
molson
serves
chairman
avenir
global
organization
uniting
seven
strategic
communications
firms
across
canada
europe
middle
east
also
chairman
molson
coors
beverage
company
member
board
directors
groupe
deschênes
dundee
corporation
ch
group
limited
partnership
owner
evenko
montreal
canadiens
previously
served
director
group
jean
coutu
pjc
chair
molson
coors
may
may
vice
chair
may
may
called
quebec
bar
studying
law
laval
university
quebec
city
also
holds
bachelor
arts
princeton
university
master
science
corporate
governance
ethics
university
london
birkbeck
college
molson
serves
several
boards
including
institute
governance
private
public
organizations
concordia
university
foundation
québec
blue
cross
evenko
foundation
emerging
talent
montreal
general
hospital
foundation
molson
foundation
family
foundation
dedicated
betterment
canadian
society
alain
trudeau
fellow
quebec
cpa
order
alain
trudeau
distinguished
career
ernst
young
held
position
managing
partner
assurance
services
ey
offices
province
quebec
also
responsible
audit
many
companies
currently
serves
board
directors
montréal
foundation
institut
de
médiation
et
arbitrage
du
québec
imaq
blue
bridge
trust
company
trudeau
lecturer
collège
des
administrateurs
de
sociétés
de
l
université
laval
quebec
city
trudeau
holds
bachelor
arts
accounting
hec
montréal
theratechnologies
theratechnologies
tsx
th
nasdaq
thtx
biopharmaceutical
company
focused
development
commercialization
innovative
therapies
addressing
unmet
medical
needs
information
theratechnologies
available
company
website
sedar
edgar
information
press
release
contains
statements
information
collectively
statements
within
meaning
applicable
securities
laws
based
management
beliefs
assumptions
information
currently
available
management
identify
statements
terms
may
could
would
outlook
believe
plan
envisage
anticipate
expect
estimate
negatives
terms
variations
statements
contained
press
release
include
limited
statements
regarding
development
tesamorelin
potential
treatment
nash
general
population
development
technologytm
platform
statements
based
upon
number
assumptions
include
limited
following
development
tesamorelin
potential
treatment
nash
general
population
development
technologytm
platform
yield
positive
results
lead
new
medicines
approved
treatment
nash
treatment
cancer
respectively
statements
subject
variety
risks
uncertainties
many
beyond
control
could
cause
actual
results
differ
materially
disclosed
implied
statements
contained
press
release
risks
uncertainty
include
risk
pandemic
materially
adversely
affect
business
plan
activities
ii
regulatory
agencies
approve
phase
study
protocol
development
tesamorelin
potential
treatment
nash
general
population
phase
study
protocol
pursue
development
peptide
conjugates
oncology
iii
even
protocols
approved
unable
recruit
sufficient
number
patients
conduct
clinical
trials
iv
incur
delays
recruiting
patients
completing
clinical
trials
v
negative
results
ensue
trials
vi
egrifta
subject
unknown
serious
adverse
events
could
lead
product
withdrawal
market
blackbox
warnings
refer
potential
investors
risk
factors
section
annual
information
form
dated
february
available
sedar
edgar
exhibit
report
form
dated
february
theratechnologies
public
filings
additional
risks
regarding
conduct
business
theratechnologies
reader
cautioned
consider
risks
uncertainties
carefully
put
undue
reliance
statements
statements
reflect
current
expectations
regarding
future
events
speak
date
press
release
represent
expectations
date
undertake
obligation
update
revise
information
contained
press
release
whether
result
new
information
future
events
circumstances
otherwise
except
may
required
applicable
law
media
inquiries
denis
boucher
vice
president
communications
corporate
affairs
